insights_auto
Hvorfor er EVGN steget med 2,18%?
Dyk dybere nedchevron_right
EVGN:NASDAQ
Evogene Ltd
0,38 US$
arrow_upward
+2,18%(+0,0081) 1D
21. okt., 13.47.00 GMT-4 · USD
search
Alle symboler
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for EVGN...
Åbn
0,37 US$
Høj
0,38 US$
Lav
0,37 US$
Markedsværdi
6,88 mio.
Gns. vol.
2,56 mio.
Volumen
21,77 t
Højeste i 52 uger
1,33 US$
Laveste i 52 uger
0,35 US$
Indtægt pr. aktie
-0,90 US$
Beta
1,44
Aktier i omløb
18,05 mio.
Antal ansatte
52
Åbn
0,37 US$
Høj
0,38 US$
Lav
0,37 US$
Markedsværdi
6,88 mio.
Gns. vol.
2,56 mio.
Volumen
21,77 t
Højeste i 52 uger
1,33 US$
Laveste i 52 uger
0,35 US$
Indtægt pr. aktie
-0,90 US$
Beta
1,44
Aktier i omløb
18,05 mio.
Antal ansatte
52
Nyhedshistorier
Fra webkilder og nyhedspartnere
Traders Union
·
for 1 dag siden
Grant Cardone: 41 AI-relaterede virksomheder udgør 49 % af S&P 500-markedet
PR Newswire
·
for 14 minutter siden
Nasdaq and Small Caps Lead Three Day Surge as Crude Slides and Blue Chips Hold Firm
CNBC
·
for 1 time siden
Why the stock market’s fragile calm faces a major test starting Friday
MarketBeat
·
for 25 minutter siden
Okta (NASDAQ:OKTA) Stock Jumps 7.2% - Time to Buy?
Profil
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters. This powerful platform significantly improves success rates while reducing development time and costs. Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products driven by the integration of scientific innovation with real-world industry needs.
In 2024, the company began collaborating with Google Cloud to develop an AI-powered generative model aimed at discovering small molecules for drug development and sustainable agriculture. Wikipedia
Om Evogene Ltd